PerkinElmer uses cookies to ensure that we give you the best experience possible on our website. This may include cookies from third party websites. If you continue without changing your settings, we will assume that you consent to receive cookies from this website. You can change your cookie settings at any time. To learn more, please review our cookie policy, which includes information on how to manage your cookies.

Horizon Discovery joins PerkinElmer at AGBT 2021

Horizon Discovery

Horizon Discovery is now a PerkinElmer business with innovative reagents, which leverage CRISPR technologies. Combined with PerkinElmer’s automation portfolio and LabChip® platforms, customers benefit from scalable workflows and quality control capabilities when working with engineered cells.

For more information on capabilities, Horizon Discovery offers, please go to